Methylphenidate hydrochloride and Lipitor drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Methylphenidate hydrochloride (methylphenidate hydrochloride) and Lipitor (atorvastatin calcium). Common drug interactions include chronic kidney disease among females and hallucination among males.
The phase IV clinical study analyzes what interactions people have when they take Methylphenidate hydrochloride and Lipitor. It is created by eHealthMe based on reports of 57 people who take the same drugs from the FDA, and is updated regularly.
What is Methylphenidate hydrochloride?
Methylphenidate hydrochloride has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 6,822 Methylphenidate hydrochloride users. Check the latest studies of Methylphenidate hydrochloride.
What is Lipitor?
Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,047 Lipitor users. Check the latest studies of Lipitor.
57 people who take Methylphenidate hydrochloride and Lipitor together, and have interactions are studied.

What are the common drug interactions of Methylphenidate Hydrochloride and Lipitor, by gender? *:
female:
- Chronic kidney disease
- Confusional state
- Death
- Decreased appetite
- Dizziness
- Faeces discoloured
- Head injury
- Infusion site bruising
- Infusion site pain
- Nausea (feeling of having an urge to vomit)
male:
- Hallucination (an experience involving the perception of something not present)
- Drug ineffective
- Agitation (state of anxiety or nervous excitement)
- Dyspnoea (difficult or laboured respiration)
- Insomnia (sleeplessness)
- Oedema peripheral (superficial swelling)
- Tremor (trembling or shaking movements in one or more parts of your body)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Cellulitis (infection under the skin)
- Chronic kidney disease
What are the common drug interactions of Methylphenidate Hydrochloride and Lipitor, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Agitation (state of anxiety or nervous excitement)
- Anger
- Bruxism (habitual grinding of the teeth, typically during sleep)
- Emotional disorder
40-49:
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Peripheral swelling
- Personality change
- Pneumonia
- Productive cough
- Rales (an abnormal respiratory sound characterized by fine crackles)
- Rash
- Respiratory disorder (respiratory disease)
- Respiratory rate increased (excess breathing rate/min)
- Respiratory tract infection
50-59:
- Agitation (state of anxiety or nervous excitement)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Depression
- Diarrhoea
- Facial palsy (paralysis of face nerve)
- Flushing (the warm, red condition of human skin)
- Hemiparesis (weakness on one side of the body)
- Hyperhidrosis (abnormally increased sweating)
- Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch)
- Insomnia (sleeplessness)
60+:
- Drug ineffective
- Pneumonia
- Weight decreased
- Abdominal pain upper
- Death
- Dry mouth
- Faeces discoloured
- Nephrogenic anaemia (anaemia due to kidney disease)
- Oropharyngeal pain
- Respiratory failure (inadequate gas exchange by the respiratory system)
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 17.54%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 14.04%
- Psychotic Disorder: 7 people, 12.28%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 12.28%
- High Blood Pressure: 7 people, 12.28%
- Depression: 7 people, 12.28%
- Hallucinations (sensations that appear real but are created by your mind): 6 people, 10.53%
- Nicotine Dependence: 5 people, 8.77%
- Pain: 4 people, 7.02%
- Hepatocellular Carcinoma (liver cancer): 4 people, 7.02%
* Approximation only. Some reports may have incomplete information.
Do you take Methylphenidate hydrochloride and Lipitor?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Methylphenidate hydrochloride (6,822 reports)
- Lipitor (259,047 reports)
Browse all drug interactions of Methylphenidate hydrochloride and Lipitor:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Methylphenidate hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lipitor:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Methylphenidate hydrochloride and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lipitor and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
- Coskun M, Adak I, "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2017 Oct .
- Yektas ?, Samurcu ND, Tufan AE, "Loss of Eyebrows (Madarosis) After Use of Long-Acting Methylphenidate: Case Report", Journal of Clinical Psychopharmacology, 2017 Aug .
- Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
- Ersoy MA, Ersoy HT, "Manic symptoms associated with isotretinoin and methylphenidate combination: a case report", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014 Sep .
- Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .
- Adak, I., & Coskun, M. , "Symptomatic cholelithiasis associated with combined use of methylphenidate and fluoxetine in an otherwise healthy adolescent girl", Psychiatry and Clinical Psychopharmacology, 2014 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Yalcin O, Aslan AA, Sari BA, Turkbay T, "Possible methylphenidate related hoarseness and disturbances of voice quality: two pediatric cases", Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2012 Sep .
- Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
- Lufi D, Bucherman M, Akita M, Cohen R, Sibani C, "The effect of methylphenidate on speech patterns of children with attention deficit disorder", Journal of Behavioral Health, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on methylphenidate hydrochloride and atorvastatin calcium (the active ingredients of Methylphenidate hydrochloride and Lipitor, respectively), and Methylphenidate hydrochloride and Lipitor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Premarin cause Belching? - 2 seconds ago
- Drug interactions of Lupron Depot and Enzalutamide - 3 seconds ago
- Could Simponi Aria cause Back Pain? - 7 seconds ago
- Could Metformin cause Pelvic Pain? - 8 seconds ago
- Drug interactions of Aminocaproic and Bisacodyl - 12 seconds ago
- Drug interactions of Imodium A-D and Venclexta - 13 seconds ago
- Could Metformin cause Metastatic Neoplasm? - 14 seconds ago
- Could Vyvanse cause Ill-Defined Disorder? - 16 seconds ago
- How effective is Flexeril for Muscle Cramps? - 18 seconds ago
- Barrett'S Oesophagus and Pain - 24 seconds ago